AT302278B - Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze - Google Patents

Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze

Info

Publication number
AT302278B
AT302278B AT344070A AT344070A AT302278B AT 302278 B AT302278 B AT 302278B AT 344070 A AT344070 A AT 344070A AT 344070 A AT344070 A AT 344070A AT 302278 B AT302278 B AT 302278B
Authority
AT
Austria
Prior art keywords
amides
esters
salts
new
production
Prior art date
Application number
AT344070A
Other languages
English (en)
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2990569A external-priority patent/JPS5010298B1/ja
Priority claimed from JP2990769A external-priority patent/JPS5010299B1/ja
Priority claimed from JP8004269A external-priority patent/JPS5010308B1/ja
Priority claimed from JP10419469A external-priority patent/JPS4939995B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Priority claimed from US00206966A external-priority patent/US3821404A/en
Application granted granted Critical
Publication of AT302278B publication Critical patent/AT302278B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT344070A 1969-04-16 1970-04-15 Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze AT302278B (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2990569A JPS5010298B1 (de) 1969-04-16 1969-04-16
JP2990769A JPS5010299B1 (de) 1969-04-16 1969-04-16
JP3416669 1969-05-02
JP3416769 1969-05-02
JP8004169 1969-10-03
JP8004269A JPS5010308B1 (de) 1969-10-03 1969-10-03
JP10280969 1969-12-19
JP10419469A JPS4939995B1 (de) 1969-12-23 1969-12-23
US2641270A 1970-04-07 1970-04-07
US00206966A US3821404A (en) 1969-04-16 1971-12-10 Phenoxy carboxylic acid derivatives as anti-atherosclerosis agents

Publications (1)

Publication Number Publication Date
AT302278B true AT302278B (de) 1972-10-10

Family

ID=27579824

Family Applications (2)

Application Number Title Priority Date Filing Date
AT784271A AT303015B (de) 1969-04-16 1970-04-15 Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze
AT344070A AT302278B (de) 1969-04-16 1970-04-15 Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT784271A AT303015B (de) 1969-04-16 1970-04-15 Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze

Country Status (9)

Country Link
US (2) US3716583A (de)
AT (2) AT303015B (de)
BE (1) BE748970A (de)
CA (1) CA964273A (de)
CH (2) CH556807A (de)
DK (1) DK128731B (de)
FI (1) FI52570C (de)
FR (1) FR2042333B1 (de)
NL (1) NL139016B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092324A (en) * 1971-05-22 1978-05-30 Sumitomo Chemical Company, Limited Diheterocyclic esters of 4-(1,1-bis-(phenoxy-propionic or -butoyric acid)-cyclohexane)α-methyl substituted
US4008265A (en) * 1971-05-22 1977-02-15 Sumitomo Chemical Company, Limited Novel bisphenoxy carboxylic acid derivatives and their salts
JPS575214B2 (de) * 1972-06-01 1982-01-29
JPS4931651A (de) * 1972-07-20 1974-03-22
JPS5735171B2 (de) * 1973-07-02 1982-07-27
AT353776B (de) * 1973-12-27 1979-12-10 Siegfried Ag Verfahren zur herstellung von neuen alkan- saeuren, deren estern und salzen
CH617417A5 (de) * 1973-12-27 1980-05-30 Siegfried Ag
FR2428629A1 (fr) * 1978-06-14 1980-01-11 Hexachimie Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique
EP0363760A1 (de) * 1988-10-12 1990-04-18 Bayer Ag Aromatische Ether
US5179097A (en) * 1991-06-10 1993-01-12 Angres Isaac A Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
HUP0303917A2 (hu) * 2001-01-26 2004-03-01 Schering Corporation Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
SK287988B6 (sk) * 2001-01-26 2012-09-03 Schering Corporation Composition, oral dosage form and use thereof
EP1911462A3 (de) 2001-01-26 2011-11-30 Schering Corporation Zusammensetzungen enthaltend einen Sterolabsorptionshemmer
ES2286233T3 (es) * 2001-01-26 2007-12-01 Schering Corporation Combinaciones de inhibidor(es) de la absorcion de esteroles con agente(s) cardiovascular(es) para el tratamiento de afecciones vasculares.
PE20020850A1 (es) * 2001-01-26 2002-09-21 Schering Corp Utilizacion de compuestos de azetidinona sustituida para tratamiento de la sitosterolemia
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
AR035739A1 (es) * 2001-01-26 2004-07-07 Schering Corp Composiciones farmaceuticas y combinaciones terapeuticas que comprenden secuestrante (s) de los acidos biliares y de inhibidor (es) de la absorcion de los esteroles y el uso de dichas composiciones para la manufactura de un medicamento para el tratamiento de indicaciones vasculares
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
EP1671650A1 (de) * 2001-01-26 2006-06-21 Schering Corporation Kombinationen von einem Hemmer der Sterol-Absorption und Nicotinsäure zur Behandlung von kardiovaskulären Indikationen
JP2004532868A (ja) * 2001-05-25 2004-10-28 シェーリング　コーポレイション アルツハイマー病の処置におけるアゼチジノン置換誘導体の使用
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
JP4395370B2 (ja) * 2001-09-21 2010-01-06 シェーリング コーポレイション ステロール吸収阻害剤を使用して血管炎症を治療または予防する方法
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
MXPA04002573A (es) * 2001-09-21 2004-06-18 Schering Corp Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol.
WO2004043457A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7192944B2 (en) * 2003-03-07 2007-03-20 Schering Corp. Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
JP4589919B2 (ja) * 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
GEP20084406B (en) * 2003-05-30 2008-06-25 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
CA2544309A1 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
US6998397B2 (en) * 2004-07-23 2006-02-14 Drebsk Comptech, Inc. Method for decreasing cholesterol level in blood
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
CN101494980A (zh) * 2006-07-14 2009-07-29 兰贝克赛实验室有限公司 HMG-CoA还原酶抑制剂的多晶型形式及其应用
AR065670A1 (es) 2007-03-09 2009-06-24 Indigene Pharmaceuticals Inc Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
TW201628625A (zh) 2015-02-06 2016-08-16 英特賽普醫藥品公司 組合療法醫藥組成物
CN104610051A (zh) * 2015-03-02 2015-05-13 北京万全德众医药生物技术有限公司 一种制备克利贝特杂质的方法
US20220226350A1 (en) 2019-05-30 2022-07-21 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2444594A (en) * 1947-08-07 1948-07-06 American Cyanamid Co Isopropylidene-p-phenoxy-2-ethanol-p-phenoxyacetic acid
US2541003A (en) * 1948-08-17 1951-02-06 American Cyanamid Co Process for reacting salts of phenols with halo-alkanoic acid compounds
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
US3169144A (en) * 1960-08-12 1965-02-09 Massarani Elena Anticholesterinemic and antilipaemic agents
GB970969A (en) * 1963-08-15 1964-09-23 Shell Int Research Dicarboxylic acids and their esters and a process for the preparation thereof
FR1380816A (fr) * 1963-11-18 1964-12-04 Ciba Geigy Procédé de préparation de nouveaux acides isobutyriques, entre autres de l'acide alpha-[p-(2-p'-chlorophényl-propyl-[2])-phénoxy]-isobutyrique
US3470234A (en) * 1965-08-23 1969-09-30 Ciba Geigy Corp Diaryl substituted benzocycloalkanes
US3470235A (en) * 1965-11-05 1969-09-30 Eastman Kodak Co Alicyclic bisphenyleneoxydicarboxylic acids,salts and esters
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
US3630715A (en) * 1968-12-19 1971-12-28 Weston Chemical Corp Alkylene bis (phenoxyacetic acid) derivatives as herbicides
US3755603A (en) * 1970-07-01 1973-08-28 Syntex Corp Biphenylyloxyacetic acids in pharmaceutical compositions

Also Published As

Publication number Publication date
FR2042333A1 (de) 1971-02-12
US3959484A (en) 1976-05-25
CH556807A (de) 1974-12-13
AT303015B (de) 1972-11-10
BE748970A (fr) 1970-09-16
NL139016B (nl) 1973-06-15
NL7005400A (de) 1970-10-20
FI52570B (de) 1977-06-30
FR2042333B1 (de) 1973-04-06
US3716583A (en) 1973-02-13
DK128731B (da) 1974-06-24
CH539012A (de) 1973-08-31
CA964273A (en) 1975-03-11
FI52570C (fi) 1977-10-10

Similar Documents

Publication Publication Date Title
AT302278B (de) Verfahren zur Herstellung neuer Phenoxyalkansäuren, deren Ester, Amide oder Salze
AT358017B (de) Verfahren zur herstellung neuer phenoxyalkan- saeuren, deren ester und salze
AT297701B (de) Verfahren zur Herstellung neuer Bistriazolyl-bisphenyl-methanen und deren Salze
CH536803A (de) Verfahren zur Herstellung neuer Naphthylpropionsäuren
AT299909B (de) Verfahren zur Herstellung von neuen Sulfamylanthranilsäuren sowie deren Salzen und Estern
CH537895A (de) Verfahren zur Herstellung neuer Hydroxycrotonsäuren
AT313875B (de) Verfahren zur Herstellung neuer basischer Ester von substituierten Alkyliden-amino-oxyalkancarbonsäuren und deren Säureadditionssalze
AT303704B (de) Verfahren zur Herstellung neuer Benzylidenaminooxyalkancarbonsäuren und deren Salze und Ester
AT314522B (de) Verfahren zur Herstellung neuer α-Phenylfettsäuren und ihrer Ester, Amide und Salze
AT310757B (de) Verfahren zur Herstellung von neuen Cinnolincarbonsäureestern und von deren pharmazeutisch zulässigen Salzen
AT303709B (de) Verfahren zur Herstellung von neuen substituierten Alkensäuren und deren Salzen, Alkylestern oder Amiden
AT297691B (de) Verfahren zur Herstellung neuer 4-Phenylbuttersäuren und deren Derivate
AT301773B (de) Verfahren zur Herstellung neuer Ester des Fluocinolon-acetonids
AT305255B (de) Verfahren zur Herstellung von neuen Anthranilsäuren und deren Salzen und Estern
CH523862A (de) Verfahren zur Herstellung neuer bis-Phenoxyessigsäuren und deren Estern
AT291292B (de) Verfahren zur Herstellung von neuer Propenyl-phosphonsäure und deren Estern und Salzen
AT313882B (de) Verfahren zur Herstellung neuen substituierten Zimtsäuren und deren Estern, Amiden oder Salzen
AT314512B (de) Verfahren zur Herstellung neuer α-[(1-Cycloalkenyl)-phenoxy]- alkansäuren sowie ihrer Ester, Amide und/oder Salze
AT308110B (de) Verfahren zur Herstellung von Fluorescein-monocarbonsäureestern und deren Salzen
CH555808A (de) Verfahren zur herstellung von l-alpha-hydrazino-betaphenylalkansaeuren, deren salzen und estern.
CH467797A (de) Verfahren zur Herstellung neuer, basisch substituierter Xanthen-9-ol-9-carbonsäureester und deren Salzen
AT308078B (de) Verfahren zur Herstellung von Zimtsäuren und deren Estern
AT280249B (de) Verfahren zur Herstellung neuer basischer Ester und deren Salze
AT314520B (de) Verfahren zur Herstellung neuer α-Phenylfettsäuren und ihrer Ester, Amide und Salze
AT314514B (de) Verfahren zur Herstellung neuer α-[(1-Cyclohexenyl)-phenoxy]- alkansäuren und ihrer Ester, Amide und Salze